Semaglutide: How It Supports Your Goals
Semaglutide is a GLP-1 receptor agonist that mimics a hormone your gut naturally releases after eating. It slows gastric emptying, reduces appetite, and helps regulate blood sugar by stimulating insulin release in a glucose-dependent manner.
Patients typically begin at a low dose, which is titrated upward over several weeks, allowing the body to adjust and minimizing gastrointestinal side effects. Semaglutide is administered as a weekly subcutaneous injection at a dose calibrated to your current weight and response.
Tirzepatide: The Next Generation of Weight Management
Tirzepatide activates both the GLP-1 and GIP receptors simultaneously, a dual-agonist mechanism that clinical trials have shown to produce greater average weight reduction than single-agonist options. GIP receptor activation appears to enhance the metabolic effects of GLP-1 stimulation.
Like semaglutide, tirzepatide for weight loss in Springs, CO, is administered weekly and dose-escalated gradually. Your provider reviews your response at each check-in and adjusts your protocol accordingly.